ABVIX | VIVIX | ABVIX / VIVIX | |
Total Expense Ratio | N/A | N/A | - |
Annual Report Gross Expense Ratio | N/A | N/A | - |
Fund Existence | 20 years | 26 years | - |
Gain YTD | 15.556 | 16.286 | 96% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 2000000 | 5000000 | 40% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 452M | 183B | 0% |
Annual Yield % from dividends | 1.28 | 2.37 | 54% |
Returns for 1 year | 20.24 | 24.01 | 84% |
Returns for 3 years | 9.05 | 28.27 | 32% |
Returns for 5 years | 37.06 | 55.47 | 67% |
Returns for 10 years | 47.89 | 114.02 | 42% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
TSMDX | 15.98 | N/A | N/A |
Trillium ESG Small/Mid Cap Institutional | |||
MTCKX | 48.71 | -0.12 | -0.25% |
MFS Technology R1 | |||
JDEAX | 44.02 | -0.16 | -0.36% |
JPMorgan US Research Enhanced Equity A | |||
GGESX | 24.35 | -0.12 | -0.49% |
Nationwide Global Sust Eq Instl Svc | |||
BRXUX | 14.04 | -0.11 | -0.78% |
MFS Blended Research Intl Eq R4 |